Table of Contents Author Guidelines Submit a Manuscript
Journal of Biomedicine and Biotechnology
Volume 2010, Article ID 274346, 14 pages
http://dx.doi.org/10.1155/2010/274346
Research Article

Expression and Immunogenicity of the Mycobacterial Ag85B/ESAT-6 Antigens Produced in Transgenic Plants by Elastin-Like Peptide Fusion Strategy

1Leibniz Institute of Plant Genetics and Crop Plant Research (IPK), Corrensstrasse 3, 06466 Gatersleben, Germany
2Institute of Biochemistry, Christian Albrechts University, Olshausenstrasse 40, 24118 Kiel, Germany
3CIRAD, UMR CMAEE, 34398 Montpellier, France
4Institut National de la Recherche Agronomique (INRA), UR1282, Infectiologie Animale et Santé Publique, 37380, Nouzilly (Tours), France
5Laboratoire “Microorganismes: Génome et Environnement” (LMGE), Equipe Interactions Hôtes-Parasites, 24, avenue des landais, 63177 Aubière Cedex, France
6CIRAD, UMR 17, 34398 Montpellier, France

Received 3 September 2009; Accepted 15 January 2010

Academic Editor: Don Mark Estes

Copyright © 2010 Doreen Manuela Floss et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. E. Etter, P. Donado, F. Jori, A. Caron, F. Goutard, and F. Roger, “Risk analysis and bovine tuberculosis, a re-emerging zoonosis,” Annals of the New York Academy of Sciences, vol. 1081, pp. 61–73, 2006. View at Publisher · View at Google Scholar · View at Scopus
  2. J. C. Hope and B. Villarreal-Ramos, “Bovine TB and the development of new vaccines,” Comparative Immunology, Microbiology and Infectious Diseases, vol. 31, no. 2-3, pp. 77–100, 2008. View at Publisher · View at Google Scholar · View at Scopus
  3. I. N. de Kantor, M. Ambroggi, S. Poggi et al., “Human Mycobacterium bovis infection in ten Latin American countries,” Tuberculosis, vol. 88, no. 4, pp. 358–365, 2008. View at Publisher · View at Google Scholar · View at Scopus
  4. M. J. Wilkins, J. Meyerson, P. C. Bartlett et al., “Human Mycobacterium bovis infection and bovine tuberculosis outbreak, Michigan, 1994–2007,” Emerging Infectious Diseases, vol. 14, no. 4, pp. 657–660, 2008. View at Google Scholar · View at Scopus
  5. R. G. Hewinson, H. M. Vordermeier, and B. M. Buddle, “Use of the bovine model of tuberculosis for the development of improved vaccines and diagnostics,” Tuberculosis, vol. 83, no. 1-3, pp. 119–130, 2003. View at Publisher · View at Google Scholar · View at Scopus
  6. I. Van Rhijn, J. Godfroid, A. Michel, and V. Rutten, “Bovine tuberculosis as a model for human tuberculosis: advantages over small animal models,” Microbes and Infection, vol. 10, no. 7, pp. 711–715, 2008. View at Publisher · View at Google Scholar · View at Scopus
  7. P. Andersen and T. M. Doherty, “The success and failure of BCG—implications for a novel tuberculosis vaccine,” Nature Reviews Microbiology, vol. 3, no. 8, pp. 656–662, 2005. View at Publisher · View at Google Scholar · View at Scopus
  8. A. W. Olsen, A. Williams, L. M. Okkels, G. Hatch, and P. Andersen, “Protective effect of a tuberculosis subunit vaccine based on a fusion of antigen 85B and ESAT-6 in the aerosol guinea pig model,” Infection and Immunity, vol. 72, no. 10, pp. 6148–6150, 2004. View at Publisher · View at Google Scholar · View at Scopus
  9. P. Andersen, “Tuberculosis vaccines—an update,” Nature Reviews Microbiology, vol. 5, no. 7, pp. 484–487, 2007. View at Publisher · View at Google Scholar · View at Scopus
  10. E. M. Agger, I. Rosenkrands, A. W. Olsen et al., “Protective immunity to tuberculosis with Ag85B-ESAT-6 in a synthetic cationic adjuvant system IC31,” Vaccine, vol. 24, no. 26, pp. 5452–5460, 2006. View at Publisher · View at Google Scholar · View at Scopus
  11. L. H. Ly and D. N. McMurray, “Tuberculosis: vaccines in the pipeline,” Expert Review of Vaccines, vol. 7, no. 5, pp. 635–650, 2008. View at Publisher · View at Google Scholar · View at Scopus
  12. R. I. Curtiss and C. A. Cardineau, “Oral immunization by transgenic plants,” World Patent Application WO 90/02484, 1990.
  13. H. S. Mason, D. M.-K. Lam, and C. J. Arntzen, “Expression of hepatitis B surface antigen in transgenic plants,” Proceedings of the National Academy of Sciences of the United States of America, vol. 89, no. 24, pp. 11745–11749, 1992. View at Publisher · View at Google Scholar · View at Scopus
  14. D. M. Floss, D. Falkenburg, and U. Conrad, “Production of vaccines and therapeutic antibodies for veterinary applications in transgenic plants: an overview,” Transgenic Research, vol. 16, no. 3, pp. 315–332, 2007. View at Publisher · View at Google Scholar · View at Scopus
  15. S. J. Streatfield, “Mucosal immunization using recombinant plant-based oral vaccines,” Methods, vol. 38, no. 2, pp. 150–157, 2006. View at Publisher · View at Google Scholar · View at Scopus
  16. V. Yusibov and S. Rabindran, “Recent progress in the development of plant-derived vaccines,” Expert Review of Vaccines, vol. 7, no. 8, pp. 1173–1183, 2008. View at Publisher · View at Google Scholar · View at Scopus
  17. Y. Thanavala, Z. Huang, and H. S. Mason, “Plant-derived vaccines: a look back at the highlights and a view to the challenges on the road ahead,” Expert Review of Vaccines, vol. 5, no. 2, pp. 249–260, 2006. View at Publisher · View at Google Scholar · View at Scopus
  18. O. Guerrero-Andrade, E. Loza-Rubio, T. Olivera-Flores, T. Fehérvári-Bone, and M. A. Gómez-Lim, “Expression of the Newcastle disease virus fusion protein in transgenic maize and immunological studies,” Transgenic Research, vol. 15, no. 4, pp. 455–463, 2006. View at Publisher · View at Google Scholar · View at Scopus
  19. A. Khandelwal, G. Lakshmi Sita, and M. S. Shaila, “Oral immunization of cattle with hemagglutinin protein of rinderpest virus expressed in transgenic peanut induces specific immune responses,” Vaccine, vol. 21, no. 23, pp. 3282–3289, 2003. View at Publisher · View at Google Scholar · View at Scopus
  20. T. Tuboly, W. Yu, A. Bailey et al., “Immunogenicity of porcine transmissible gastroenteritis virus spike protein expressed in plants,” Vaccine, vol. 18, no. 19, pp. 2023–2028, 2000. View at Publisher · View at Google Scholar · View at Scopus
  21. J. Patel, H. Zhu, R. Menassa, L. Gyenis, A. Richman, and J. Brandle, “Elastin-like polypeptide fusions enhance the accumulation of recombinant proteins in tobacco leaves,” Transgenic Research, vol. 16, no. 2, pp. 239–249, 2007. View at Publisher · View at Google Scholar · View at Scopus
  22. J. Scheller, D. Henggeler, A. Viviani, and U. Conrad, “Purification of spider silk-elastin from transgenic plants and application for human chondrocyte proliferation,” Transgenic Research, vol. 13, no. 1, pp. 51–57, 2004. View at Publisher · View at Google Scholar · View at Scopus
  23. J. Scheller, M. Leps, and U. Conrad, “Forcing single-chain variable fragment production in tobacco seeds by fusion to elastin-like polypeptides,” Plant Biotechnology Journal, vol. 4, no. 2, pp. 243–249, 2006. View at Publisher · View at Google Scholar · View at Scopus
  24. D. M. Floss, M. Sack, J. Stadlmann et al., “Biochemical and functional characterization of anti-HIV antibody-ELP fusion proteins from transgenic plants,” Plant Biotechnology Journal, vol. 6, no. 4, pp. 379–391, 2008. View at Publisher · View at Google Scholar · View at Scopus
  25. D. M. Floss, M. Sack, E. Arcalis et al., “Influence of elastin-like peptide fusions on the quantity and quality of a tobacco-derived human immunodeficiency virus-neutralizing antibody,” Plant Biotechnology Journal, vol. 7, no. 9, pp. 899–913, 2009. View at Publisher · View at Google Scholar · View at Scopus
  26. B. Li and V. Daggett, “Molecular basis for the extensibility of elastin,” Journal of Muscle Research and Cell Motility, vol. 23, no. 5-6, pp. 561–573, 2002. View at Publisher · View at Google Scholar · View at Scopus
  27. D. E. Meyer and A. Chilkoti, “Purification of recombinant proteins by fusion with thermally-responsive polypeptides,” Nature Biotechnology, vol. 17, no. 11, pp. 1112–1115, 1999. View at Publisher · View at Google Scholar · View at Scopus
  28. A. J. Conley, J. J. Joensuu, A. M. Jevnikar, R. Menassa, and J. E. Brandle, “Optimization of elastin-like polypeptide fusions for expression and purification of recombinant proteins in plants,” Biotechnology and Bioengineering, vol. 103, no. 3, pp. 562–573, 2009. View at Publisher · View at Google Scholar · View at Scopus
  29. M. Lin, S. Rose-John, J. Grotzinger, U. Conrad, and J. Scheller, “Functional expression of a biologically active fragment of soluble gp130 as an ELP-fusion protein in transgenic plants: purification via inverse transition cycling,” Biochemical Journal, vol. 398, no. 3, pp. 577–583, 2006. View at Publisher · View at Google Scholar · View at Scopus
  30. J. C. Rodriguez-Cabello, S. Prieto, J. Reguera, F. J. Arias, and A. Ribeiro, “Biofunctional design of elastin-like polymers for advanced applications in nanobiotechnology,” Journal of Biomaterials Science, Polymer Edition, vol. 18, no. 3, pp. 269–286, 2007. View at Publisher · View at Google Scholar · View at Scopus
  31. D. Raucher, I. Massodi, and G. L. Bidwell III, “Thermally targeted delivery of chemotherapeutics and anti-cancer peptides by elastin-like polypeptide,” Expert Opinion on Drug Delivery, vol. 5, no. 3, pp. 353–369, 2008. View at Publisher · View at Google Scholar · View at Scopus
  32. D. M. Floss, K. Schallau, S. Rose-John, U. Conrad, and J. Scheller, “Elastin-like polypeptides revolutionize recombinant protein expression and their biomedical application,” Trends in Biotechnology, vol. 28, no. 1, pp. 37–45, 2010. View at Publisher · View at Google Scholar · View at Scopus
  33. D. W. Urry, T. M. Parker, M. C. Reid, and D. C. Gowda, “Biocompatibility of the bioelastic materials, poly(GVGVP) and its γ-irradiation cross-linked matrix: summary of generic biological test results,” Journal of Bioactive and Compatible Polymers, vol. 6, no. 3, pp. 263–282, 1991. View at Google Scholar · View at Scopus
  34. A. Chilkoti, T. Christensen, and J. A. MacKay, “Stimulus responsive elastin biopolymers: applications in medicine and biotechnology,” Current Opinion in Chemical Biology, vol. 10, no. 6, pp. 652–657, 2006. View at Publisher · View at Google Scholar · View at Scopus
  35. Y. Nakamura, T. Gojobori, and T. Ikemura, “Codon usage tabulated from international DNA sequence databases: status for the year 2000,” Nucleic Acids Research, vol. 28, no. 1, p. 292, 2000. View at Google Scholar · View at Scopus
  36. N. Bohorova, R. Frutos, M. Royer et al., “Novel synthetic Bacillus thuringiensis cry1B gene and the cry1B-cry1Ab translational fusion confer resistance to southwestern corn borer, sugarcane borer and fall armyworm in transgenic tropical maize,” Theoretical and Applied Genetics, vol. 103, no. 6-7, pp. 817–826, 2001. View at Publisher · View at Google Scholar · View at Scopus
  37. J.-C. Breitler, V. Marfà, M. Royer et al., “Expression of a Bacillus thuringiensis cry1B synthetic gene protects Mediterranean rice against the striped stem borer,” Plant Cell Reports, vol. 19, no. 12, pp. 1195–1202, 2000. View at Publisher · View at Google Scholar · View at Scopus
  38. G. W. Almond, “Research applications using pigs,” The Veterinary Clinics of North America. Food Animal Practice, vol. 12, no. 3, pp. 707–716, 1996. View at Google Scholar
  39. C. A. Bolin, D. L. Whipple, K. V. Khanna, J. M. Risdahl, P. K. Peterson, and T. W. Molitor, “Infection of swine with Mycobacterium bovis as a model of human tuberculosis,” Journal of Infectious Diseases, vol. 176, no. 6, pp. 1559–1566, 1997. View at Google Scholar · View at Scopus
  40. C. Prodromou and L. H. Pearl, “Recursive PCR: a novel technique for total gene synthesis,” Protein Engineering, vol. 5, no. 8, pp. 827–829, 1992. View at Google Scholar · View at Scopus
  41. A. Franck, H. Guilley, G. Jonard, K. Richards, and L. Hirth, “Nucleotide sequence of cauliflower mosaic virus DNA,” Cell, vol. 21, no. 1, pp. 285–294, 1980. View at Google Scholar · View at Scopus
  42. J. T. Odell, F. Nagy, and N.-H. Chua, “Identification of DNA sequences required for activity of the cauliflower mosaic virus 35S promoter,” Nature, vol. 313, no. 6005, pp. 810–812, 1985. View at Google Scholar · View at Scopus
  43. H. Bäumlein, U. Wobus, J. Pustell, and F. C. Kafatos, “The legumin gene family: structure of a B type gene of Vicia faba and a possible legumin gene specific regulatory element,” Nucleic acids research, vol. 14, no. 6, pp. 2707–2720, 1986. View at Google Scholar · View at Scopus
  44. S. Munro and H. R. B. Pelham, “An hsp70-like protein in the ER: identity with the 78 kd glucose-regulated protein and immunoglobulin heavy chain binding protein,” Cell, vol. 46, no. 2, pp. 291–300, 1986. View at Google Scholar · View at Scopus
  45. M. Gahrtz and U. Conrad, “Immunomodulation of plant function by in vitro selected single-chain Fv intrabodies,” in Methods in Molecular Biology: Recombinant Proteins from Plants, L. Faye and V. Gomord, Eds., pp. 289–312, Humana Press, Totowa, NJ, USA, 2009. View at Google Scholar
  46. C. Xiang, P. Han, I. Lutziger, K. Wang, and D. J. Oliver, “A mini binary vector series for plant transformation,” Plant Molecular Biology, vol. 40, no. 4, pp. 711–717, 1999. View at Publisher · View at Google Scholar · View at Scopus
  47. R. Deblaere, B. Bytebier, H. De Greve et al., “Efficient octopine Ti plasmid-derived vectors for Agrobacterium-mediated gene transfer to plants,” Nucleic Acids Research, vol. 13, no. 13, pp. 4777–4788, 1985. View at Google Scholar · View at Scopus
  48. J. Kapila, R. De Rycke, M. Van Montagu, and G. Angenon, “An Agrobacterium-mediated transient gene expression system for intact leaves,” Plant Science, vol. 122, no. 1, pp. 101–108, 1997. View at Google Scholar · View at Scopus
  49. C. Vaquero, M. Sack, J. Chandler et al., “Transient expression of a tumor-specific single-chain fragment and a chimeric antibody in tobacco leaves,” Proceedings of the National Academy of Sciences of the United States of America, vol. 96, no. 20, pp. 11128–11133, 1999. View at Publisher · View at Google Scholar · View at Scopus
  50. R. B. Horsch, J. E. Fry, N. L. Hoffmann, D. Eichholtz, S. G. Rogers, and R. T. Fraley, “A simple and general method for transferring genes into plants,” Science, vol. 227, no. 4691, pp. 1229–1230, 1985. View at Google Scholar · View at Scopus
  51. T. Murashige and F. Skoog, “A revised medium for rapid growth and bio assays with tobacco tissue cultures,” Physiologia Plantarum, vol. 15, pp. 473–497, 1962. View at Google Scholar
  52. K. Inaba, M. Inaba, N. Romani et al., “Generation of large numbers of dendritic cells from mouse bone marrow cultures supplemented with granulocyte/macrophage colony-stimulating factor,” Journal of Experimental Medicine, vol. 176, no. 6, pp. 1693–1702, 1992. View at Publisher · View at Google Scholar · View at Scopus
  53. L. Dedieu, E. Chapey, and V. Balcer-Rodrigues, “Mycoplasma mycoides ssp. mycoides biotype small colony-secreted components induce apoptotic cell death in bovine leucocytes,” Scandinavian Journal of Immunology, vol. 62, no. 6, pp. 528–538, 2005. View at Publisher · View at Google Scholar · View at Scopus
  54. J. C. Hope, D. Werling, R. A. Collins, B. Mertens, and C. J. Howard, “Flt-3 ligand, in combination with bovine granulocyte-macrophage colony- stimulating factor and interleukin-4, promotes the growth of bovine bone marrow derived dendritic cells,” Scandinavian Journal of Immunology, vol. 51, no. 1, pp. 60–66, 2000. View at Publisher · View at Google Scholar · View at Scopus
  55. A. W. Olsen, L. A. H. Van Pinxteren, L. M. Okkels, P. B. Rasmussen, and P. Andersen, “Protection of mice with a tuberculosis subunit vaccine based on a fusion protein of antigen 85B and ESAT-6,” Infection and Immunity, vol. 69, no. 5, pp. 2773–2778, 2001. View at Publisher · View at Google Scholar · View at Scopus
  56. R. C. MacDonald, R. I. MacDonald, B. P. M. Menco, K. Takeshita, N. K. Subbarao, and L.-R. Hu, “Small-volume extrusion apparatus for preparation of large, unilamellar vesicles,” Biochimica et Biophysica Acta, vol. 1061, no. 2, pp. 297–303, 1991. View at Publisher · View at Google Scholar · View at Scopus
  57. X. Ge, K. Trabbic-Carlson, A. Chilkoti, and C. D. M. Filipe, “Purification of an elastin-like fusion protein by microfiltration,” Biotechnology and Bioengineering, vol. 95, no. 3, pp. 424–432, 2006. View at Publisher · View at Google Scholar · View at Scopus
  58. M. Shimazu, A. Mulchandani, and W. Chen, “Thermally triggered purification and immobilization of elastin-OPH fusions,” Biotechnology and Bioengineering, vol. 81, no. 1, pp. 74–79, 2003. View at Publisher · View at Google Scholar · View at Scopus
  59. L. Santi, A. Giritch, C. J. Roy et al., “Protection conferred by recombinant Yersinia pestis antigens produced by a rapid and highly scalable plant expression system,” Proceedings of the National Academy of Sciences of the United States of America, vol. 103, no. 4, pp. 861–866, 2006. View at Publisher · View at Google Scholar · View at Scopus
  60. A. M. Zelada, G. Calamante, M. de la Paz Santangelo et al., “Expression of tuberculosis antigen ESAT-6 in Nicotiana tabacum using a potato virus X-based vector,” Tuberculosis, vol. 86, no. 3-4, pp. 263–267, 2006. View at Publisher · View at Google Scholar · View at Scopus
  61. R. E. Weir, P. E. M. Fine, S. Floyd et al., “Comparison of IFN-? responses to mycobacterial antigens as markers of response to BCG vaccination,” Tuberculosis, vol. 88, no. 1, pp. 31–38, 2008. View at Publisher · View at Google Scholar · View at Scopus
  62. E. M. Agger, J. P. Cassidy, J. Brady, K. S. Korsholm, C. Vingsbo-Lundberg, and P. Andersen, “Adjuvant modulation of the cytokine balance in Mycobacterium tuberculosis subunit vaccines; immunity, pathology and protection,” Immunology, vol. 124, no. 2, pp. 175–185, 2008. View at Publisher · View at Google Scholar · View at Scopus
  63. B. M. Buddle, D. N. Wedlock, M. Denis, and M. A. Skinner, “Identification of immune response correlates for protection against bovine tuberculosis,” Veterinary Immunology and Immunopathology, vol. 108, no. 1-2, pp. 45–51, 2005. View at Publisher · View at Google Scholar · View at Scopus
  64. I. M. Orme, “The use of animal models to guide rational vaccine design,” Microbes and Infection, vol. 7, no. 5-6, pp. 905–910, 2005. View at Publisher · View at Google Scholar · View at Scopus
  65. M. V. B. S. Martins, M. C. B. S. Lima, N. C. Duppre et al., “The level of PPD-specific IFN-?-producing CD4+ T cells in the blood predicts the in vivo response to PPD,” Tuberculosis, vol. 87, no. 3, pp. 202–211, 2007. View at Publisher · View at Google Scholar · View at Scopus
  66. T. F. Pais, R. A. Silva, B. Smedegaard, R. Appelberg, and P. Andersen, “Analysis of T cells recruited during delayed-type hypersensitivity to purified protein derivative (PPD) versus challenge with tuberculosis infection,” Immunology, vol. 95, no. 1, pp. 69–75, 1998. View at Publisher · View at Google Scholar · View at Scopus
  67. M. Harboe, A. S. Malin, H. S. Dockrell et al., “B-cell epitopes and quantification of the ESAT-6 protein of Mycobacterium tuberculosis,” Infection and Immunity, vol. 66, no. 2, pp. 717–723, 1998. View at Google Scholar · View at Scopus
  68. M. M. Rigano, S. Dreitz, A.-P. Kipnis, A. A. Izzo, and A. M. Walmsley, “Oral immunogenicity of a plant-made, subunit, tuberculosis vaccine,” Vaccine, vol. 24, no. 5, pp. 691–695, 2006. View at Publisher · View at Google Scholar · View at Scopus
  69. S. R. Ong, K. A. Trabbic-Carlson, D. L. Nettles, D. W. Lim, A. Chilkoti, and L. A. Setton, “Epitope tagging for tracking elastin-like polypeptides,” Biomaterials, vol. 27, no. 9, pp. 1930–1935, 2006. View at Publisher · View at Google Scholar · View at Scopus
  70. M. F. Shamji, H. Betre, V. B. Kraus et al., “Development and characterization of a fusion protein between thermally responsive elastin-like polypeptide and interleukin-1 receptor antagonist: sustained release of a local antiinflammatory therapeutic,” Arthritis and Rheumatism, vol. 56, no. 11, pp. 3650–3661, 2007. View at Publisher · View at Google Scholar · View at Scopus